HomeXVIVO • STO
add
Xvivo Perfusion AB
Previous close
kr 313.80
Day range
kr 300.60 - kr 322.20
Year range
kr 238.20 - kr 547.00
Market cap
9.54B SEK
Avg Volume
186.16K
P/E ratio
55.70
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 133.81M | 15.24% |
Net income | -12.40M | -154.42% |
Net profit margin | -5.67 | -146.29% |
Earnings per share | -0.30 | -140.55% |
EBITDA | 31.94M | 11.91% |
Effective tax rate | 11.76% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 315.87M | -38.20% |
Total assets | — | — |
Total liabilities | 202.68M | -19.10% |
Total equity | 2.09B | — |
Shares outstanding | 31.50M | — |
Price to book | 4.72 | — |
Return on assets | — | — |
Return on capital | 3.08% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -12.40M | -154.42% |
Cash from operations | -15.25M | -1,058.58% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -99.65M | -185.24% |
Free cash flow | -57.76M | -595.50% |
About
Founded
1998
Website
Employees
190
